Cargando…

An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma

SIMPLE SUMMARY: Mesothelioma is a deadly disease with few treatment options. Phytocannabinoids derived from the cannabis plant are garnering interest for their anti-cancer properties, however very little is known about their effects in mesothelioma. We aimed to assess whether phytocannabinoids have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colvin, Emily K., Hudson, Amanda L., Anderson, Lyndsey L., Kumar, Ramyashree Prasanna, McGregor, Iain S., Howell, Viive M., Arnold, Jonathon C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367527/ https://www.ncbi.nlm.nih.gov/pubmed/35954477 http://dx.doi.org/10.3390/cancers14153813

Ejemplares similares

Olivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndrome
por: Anderson, Lyndsey L., et al.
Publicado: (2022)

Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma
por: Hudson, Amanda L., et al.
Publicado: (2014)

Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
por: Anderson, Lyndsey L., et al.
Publicado: (2019)

Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
por: Swift, Wendy, et al.
Publicado: (2013)

Sub-acute Toxicity in Non-cancerous Tissue and Immune-Related Adverse Events of a Novel Combination Therapy for Cancer
por: McKelvey, Kelly J., et al.
Publicado: (2020)

Beyond CBD: Inhibitory effects of lesser studied phytocannabinoids on human voltage-gated sodium channels
por: Milligan, Carol J., et al.
Publicado: (2023)

Why the dual origins of high grade serous ovarian cancer matter
por: Colvin, Emily K., et al.
Publicado: (2020)

CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist
por: Kevin, Richard C., et al.
Publicado: (2019)

The Extracellular Matrix in Epithelial Ovarian Cancer – A Piece of a Puzzle
por: Cho, Angela, et al.
Publicado: (2015)

Modelling Epithelial Ovarian Cancer in Mice: Classical and Emerging Approaches
por: Zakarya, Razia, et al.
Publicado: (2020)

MEPIRAPIM-derived synthetic cannabinoids inhibit T-type calcium channels with divergent effects on seizures in rodent models of epilepsy
por: Harman, Thomas, et al.
Publicado: (2023)

A nutraceutical product, extracted from Cannabis sativa, modulates voltage-gated sodium channel function
por: Milligan, Carol J., et al.
Publicado: (2022)

The anticonvulsant phytocannabinoids CBGVA and CBDVA inhibit recombinant T-type channels
por: Udoh, Michael, et al.
Publicado: (2022)

Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model
por: McKelvey, Kelly J., et al.
Publicado: (2020)

Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11
por: Kevin, Richard C., et al.
Publicado: (2022)

Evaluation of the Possible Anticonvulsant Effect of Δ(9)-Tetrahydrocannabinolic Acid in Murine Seizure Models
por: Benson, Melissa J., et al.
Publicado: (2022)

Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in mice
por: Spencer, Jarrah R., et al.
Publicado: (2013)

Functional prediction of long non-coding RNAs in ovarian cancer-associated fibroblasts indicate a potential role in metastasis
por: Vafaee, Fatemeh, et al.
Publicado: (2017)

Expression of long noncoding RNAs in cancer‐associated fibroblasts linked to patient survival in ovarian cancer
por: Colvin, Emily K., et al.
Publicado: (2020)

Preclinical Models of Malignant Mesothelioma
por: Testa, Joseph R., et al.
Publicado: (2020)

Prescribing medicinal cannabis
por: Arnold, Jonathon C, et al.
Publicado: (2020)

BAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic state
por: Rath, Emma M., et al.
Publicado: (2018)

The Biology of Malignant Mesothelioma and the Relevance of Preclinical Models
por: Blanquart, Christophe, et al.
Publicado: (2020)

Use of preclinical models for malignant pleural mesothelioma
por: Shamseddin, Marie, et al.
Publicado: (2021)

The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence
por: Arnold, Jonathon C., et al.
Publicado: (2022)

Culture Models to Define Key Mediators of Cancer Matrix Remodeling
por: Fuller, Emily Suzanne, et al.
Publicado: (2014)

Adolescent Oxytocin Exposure Causes Persistent Reductions in Anxiety and Alcohol Consumption and Enhances Sociability in Rats
por: Bowen, Michael T., et al.
Publicado: (2011)

Absence of Entourage: Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Functional Activity of Δ(9)-THC at Human CB(1) and CB(2) Receptors
por: Santiago, Marina, et al.
Publicado: (2019)

The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients
por: Jackson, Melissa A., et al.
Publicado: (2021)

Cannabinoids and Dementia: A Review of Clinical and Preclinical Data
por: Walther, Sebastian, et al.
Publicado: (2010)

Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
por: Ladin, Daniel A., et al.
Publicado: (2016)

Cannabinoids as anticancer drugs: current status of preclinical research
por: Hinz, Burkhard, et al.
Publicado: (2022)

Glioblastoma Recurrence Correlates With Increased APE1 and Polarization Toward an Immuno-Suppressive Microenvironment
por: Hudson, Amanda L., et al.
Publicado: (2018)

Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy
por: Anderson, Lyndsey L., et al.
Publicado: (2021)

Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma
por: Anobile, Dario P., et al.
Publicado: (2021)

In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA
por: Kevin, Richard C., et al.
Publicado: (2017)

Editorial: Cannabinoid interactions with ion channels, receptors, and the bio-membrane
por: Ghovanloo, Mohammad-Reza, et al.
Publicado: (2023)

Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy
por: Tamba, Bogdan Ionel, et al.
Publicado: (2020)

Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
por: Ladin, Daniel A., et al.
Publicado: (2021)

Molecular Heterogeneity in Glioblastoma: Potential Clinical Implications
por: Parker, Nicole Renee, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jo9ra4h3viu1fbdo8g3o343djk